|
Re: Couple interesting tidbits from Financials
|
4
|
Resverlogix Corp.
|
Jul 30, 2019 08:33AM
|
|
Re: Would be nice if....
|
2
|
Resverlogix Corp.
|
Jul 29, 2019 05:07PM
|
|
Re: Would be nice if....
|
5
|
Resverlogix Corp.
|
Jul 29, 2019 11:03AM
|
|
Re: Soliciting a loan to shorters
|
1
|
Resverlogix Corp.
|
Jul 26, 2019 08:21PM
|
|
Re: Soliciting a loan to shorters
|
3
|
Resverlogix Corp.
|
Jul 26, 2019 12:37PM
|
|
Re: no interest
|
3
|
Resverlogix Corp.
|
Jul 22, 2019 02:22PM
|
|
Re: Resverlogix Announces Publication on Apabetalone in Clinical Epigenetics
|
7
|
Resverlogix Corp.
|
Jul 15, 2019 02:12PM
|
|
Re: Resverlogix Announces Publication on Apabetalone in Clinical Epigenetics
|
3
|
Resverlogix Corp.
|
Jul 15, 2019 11:02AM
|
|
Re: Patient Years & MACE rate Question
|
4
|
Resverlogix Corp.
|
Jul 11, 2019 12:16PM
|
|
Re: Patient Years & MACE rate Question
|
1
|
Resverlogix Corp.
|
Jul 11, 2019 11:49AM
|
|
Re: Patient Years & MACE rate Question
|
2
|
Resverlogix Corp.
|
Jul 11, 2019 11:10AM
|
|
Re: Patient Years & MACE rate Question
|
7
|
Resverlogix Corp.
|
Jul 11, 2019 10:47AM
|
|
Re: Patient Years & MACE rate Question
|
2
|
Resverlogix Corp.
|
Jul 11, 2019 10:37AM
|
|
Re: Patient Years & MACE rate Question
|
1
|
Resverlogix Corp.
|
Jul 11, 2019 09:54AM
|
|
Re: Patient Years & MACE rate Question
|
8
|
Resverlogix Corp.
|
Jul 11, 2019 08:33AM
|
|
Patient Years & MACE rate Question
|
1
|
Resverlogix Corp.
|
Jul 10, 2019 06:24PM
|
|
Re: Resverlogix’s BETonMACE Phase 3 Epigenetics Trial Completes Final Safety Visits
|
3
|
Resverlogix Corp.
|
Jul 08, 2019 09:31AM
|
|
Amarin Market Cap
|
8
|
Resverlogix Corp.
|
Jul 07, 2019 11:00AM
|
|
Re: No ESC 2019 Late Breaker
|
3
|
Resverlogix Corp.
|
Jul 02, 2019 02:34PM
|
|
Re: RRR %
|
2
|
Resverlogix Corp.
|
Jul 01, 2019 04:19PM
|
